Donoghue Forlines’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,746
| Closed | -$1.48M | – | 243 |
|
|
2024
Q1 | $1.48M | Sell |
2,746
-116
| -4% | -$62.6K | 0.42% | 74 |
|
|
2023
Q4 | $1.59M | Buy |
2,862
+269
| +10% | +$149K | 0.5% | 43 |
|
|
2023
Q3 | $1.13M | Sell |
2,593
-5
| -0.2% | -$2.19K | 0.4% | 83 |
|
|
2023
Q2 | $1.3M | Buy |
+2,598
| New | +$1.3M | 0.41% | 57 |
|
|
2022
Q1 | – | Sell |
-2,945
| Closed | -$1.94M | – | 281 |
|
|
2021
Q4 | $1.94M | Buy |
2,945
+152
| +5% | +$100K | 0.33% | 55 |
|
|
2021
Q3 | $1.74M | Sell |
2,793
-416
| -13% | -$259K | 0.34% | 69 |
|
|
2021
Q2 | $2.03M | Sell |
3,209
-217
| -6% | -$137K | 0.38% | 57 |
|
|
2021
Q1 | $1.68M | Buy |
+3,426
| New | +$1.68M | 0.33% | 78 |
|
|
2019
Q3 | – | Sell |
-9,580
| Closed | -$2.64M | – | 171 |
|
|
2019
Q2 | $2.64M | Buy |
+9,580
| New | +$2.64M | 0.31% | 80 |
|
|
2018
Q2 | – | Sell |
-12,864
| Closed | -$2.46M | – | 166 |
|
|
2018
Q1 | $2.46M | Buy |
+12,864
| New | +$2.46M | 0.21% | 78 |
|